Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 12
Submit an article Journal homepage
35
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Trofosfamide as Salvage Therapy for Anaplastic Large Cell Lymphoma Relapsing After High-dose Chemotherapy

P.O. Andersson Haematology and Coagulation Section, Sahlgrenska University Hospital, S-413 45, Göteborg, Sweden
,
I. Braide Haematology and Coagulation Section, Sahlgrenska University Hospital, S-413 45, Göteborg, Sweden
&
H. Nilsson-Ehle Haematology and Coagulation Section, Sahlgrenska University Hospital, S-413 45, Göteborg, Sweden
Pages 2351-2353 | Published online: 01 Jul 2009

  • Stein, H., Foss, H.D., Durkop, H., Marafioti, T., Delsol, G. Pulford. K., Pileri, S. and Falini, B. (2000) "CD30(+) anaplastie large cell lymphoma: a review of its hisiopathologic, genetic, and clinical features". Blood 96, 3681-3695.
  • Falini, B., Pileri, S., Zinzani, P.L., Carbone, A., Zagonel, V., WoIfPeeters, C., Verhoef, G., Menestrina, K. Tudeschini, G., Paulli, M., Lazzarino, M., Giardini, R., Aiello, A., Foss., H.D., Araujo, I., Fizzotti, M., Pelicci, P.G., Flenght, L. Martelli, M.F. and Santucci, A. (1999) "ALK,+ lymphoma: elinco-pathological findings and outcome". Blood 93, 2697-2706.
  • Gascoyne, R.D., Aoun, P., Wu, D., Chhanabhai, M., Skinnider, B.F., Greiner, T.C., Morris, S.W., Connors, J.M., Vose, J.M., Viswanatha, D.S., Coldman, A. and Weisenburger, D.D. (1999) "Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults wiih anaplastic large cell lymphoma". Blood 93, 3913-3921.
  • Fanin, R., Ruiz de Elvira, MC., Sperotto, A., Baccarani, M. and Goldsterne, A. (1999) "Autologoas stem cell transplantation for T and null cell CD30-pusitive anaplastic large cell lymphoma: analysis of (A adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT)". Bone Marrow Transplantation 23, 437-442.
  • Helsing, M.D, (1997) "Trofosfamide as a salvage treatment with low toxicity in malignant lymphoma. A phase II study". European Journal of Cancer 33, 500-502.
  • Salminen, E., Nikkauen, V. and Lindholm, L. (1997) "Palliafive chemotherapy in non-Hodgkin"s lymphoma", Oncology 54. 108-111.
  • Wisi, E, and Risberg, T. (1991) "Trofosfamide in non-Hodgkin's lymphoma. A phase II study". Acta Oncologica 30, 819-821.
  • Potzi, P., Aiginger, P, and Kuhbock, J. (1979) "Ixoten therapy in malignant lymphomas", Acta Medica Austriaca 6, 247-249.
  • Dhedin, N., Giraudier, S., Gsuilard, P., Esperon, H., lfrah, N., Michaliet, M., Milpied, N., Rio, B., Cahn, J.Y., Molina, L., Laporfe, J.L., Guilhot, F. and Kuentz, M. (1999) "Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphomai: a series of 7.3 patientsfrom the SFGM database. Societ Francaise de Greffe de Moelle". British Journal of Haemttlology 107, 154-161.
  • Juckett, M., Rowlings, P., Hessner, M., Keever-Taylor, C., Burns. W., Camitta, B., Casper, J., Drobyski, W.R., Hanson, G., Horowitz, M., Lawton, C., Margolis, J., Peitryga, D. and Vesole, D. (1998) "T cell-depleted allogeneic bone marrow transplantation for highrisk non-Hodgkin's lymphoma: clinical and molecular follow-up". Bone Marrow Transplantation 21, 893-899.
  • Mendoza, E., Territo, M., Schiller, G., LiIl, M., Kunkel, L. and Wolin, M. (1995) "Aliogeneic hone marrow transplantation for Hodgkin's and non-Hodgkin"s lymphoma". Bone Marrow Tnansplantation 15, 299-303,
  • Stein, R.S., Greer, J.P., Goodman, S., Brandi, S.J., Morgan, D., Macon, W.R., McCurley, T.L. and Wolff, S.N. (2001) "lntensified preparative regimens and allogeneic transplantation in refractory or relapsed intermediate and high grade non-Hodgkin's lymohoma". Leukemia and Lymphoma 41, 343-352.
  • Boos, J., Kupker, F., Blaschke, G, and Jurgens, H. (1993) "Trofosfamide metabolism in different species-ifosfamide is the predominant metabolite". Cancer Chemotherapy and Pharmacology. 33, 71-76.
  • Matar, P., Rozados, V.R., Gonzalez, A.D., Dlugovitzky, D.G., Bongill, R.D. and Seharovsky, O.G. (2000) "Mechanism of antimetastic immunupotentiation by low-dose cyclnphosphamide". European Journal of Cancer 36, 1060-1066.
  • Awwad, M. and North, R.J. (1988) "Cyclophosphamide (Cy)facifitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden". Immunology 65, 87-92.
  • Tzai, T.S., Lin, J.S and Chow, N.H. (1996) "Modulation of antitumor immunity of tumour-bearing mice with low-dose cyclophosphamide". Journal of Surgery Research 65, 139 - 144.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.